Samsung Biologics, Foreign Investors Net Sell 7,000 Shares... Stock Price -0.48%
Samsung Biologics ranked among the top searched stocks on 3 days within the past month.
As of 11:31 AM on the 9th, Samsung Biologics is trading at 824,000 KRW, down 0.48% from the previous day. This represents a 9.43% increase compared to November 12. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreign investors are tentatively recorded as net sellers of 7,000 shares. Over the past 5 days, individual investors have net sold 147,502 shares, while foreign and institutional investors have net bought 88,147 shares and 70,896 shares, respectively.
On December 7, Samsung Biologics was a market topic with the headline "New high due to positive factors such as COVID-19 treatment CMO."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
